PerspectivePublished 18 August 2026Does generative AI mean the “end of history” for pharmacovigilance automation? towards a framework for the future of human-AI systemsLeihong Wu · Joshua Xu · Oanh Dang · Robert BallFrontiers in Drug Safety and Regulationdoi 10.3389/fdsfr.2026.1846339
Drug Safety and RegulationPublished 16 September 2025Rethinking drug safety signal detection and causality assessment in the age of AI: the risks of incomplete data and biased insightsPriyanka Chhikara · Tarek A. HammadFrontiers in Drug Safety and Regulationdoi 10.3389/fdsfr.2025.1678074
